Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk reduction, after getting a green light from the EMA's human medicine committee.

KUWAIT CITY, Dec 11: The Public Authority for Food and Nutrition (PAFN), in coordination with the Ministry of Commerce and Industry, shut down a butcher shop in Shuwaikh Industrial for mislabeling the ...

TOLEDO, Ohio (WTVG) - A local woman is speaking out about addiction after losing her father to an overdose. She says the stigma of drug use labeled them the black sheep of the family. She wants to ...

A visiting Harvard Law professor from Brazil whose visa was revoked after he was charged with firing a BB gun near a synagogue during Yom Kippur has left the United States, the Department of Homeland ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Julia Pugachevsky Every time Julia publishes a story, you’ll get an alert straight to your ...